Thresholds of CD4 cells for initiating trimethoprim-sulfamethoxazole prophylaxis in west Africa. - Suppr | 超能文献

Thresholds of CD4 cells for initiating trimethoprim-sulfamethoxazole prophylaxis in west Africa.

作者信息

Anglaret X, Toure S, Ouassa T, Dabis F, N'Dri-Yoman T

机构信息

Programme PAC-CI, Abidjan, Côte d' Ivoire.

出版信息

AIDS. 2000 Nov 10;14(16):2628-9. doi: 10.1097/00002030-200011100-00036.

DOI:10.1097/00002030-200011100-00036

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Thresholds of CD4 cells for initiating trimethoprim-sulfamethoxazole prophylaxis in west Africa.

AIDS. 2000 Nov 10;14(16):2628-9. doi: 10.1097/00002030-200011100-00036.

2

Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial.

Lancet. 1999 May 1;353(9163):1469-75. doi: 10.1016/s0140-6736(99)03465-0.

3

Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Cotrimo-CI Study Group.

Lancet. 1999 May 1;353(9163):1463-8. doi: 10.1016/s0140-6736(98)07399-1.

4

Dietary problems in African HIV-1-infected adults, Abidjan, Côte d'Ivoire. COTRIMO-CI Study Group.

J Acquir Immune Defic Syndr. 2000 Apr 1;23(4):357-8. doi: 10.1097/00126334-200004010-00014.

5

The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'Ivoire.

Antivir Ther. 2007;12(4):543-51.

6

Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire.

N Engl J Med. 2006 Sep 14;355(11):1141-53. doi: 10.1056/NEJMsa060247.

7

Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysis.

AIDS. 2005 Aug 12;19(12):1299-308. doi: 10.1097/01.aids.0000180101.80888.c6.

8

Pneumocystis carinii pneumonia after cessation of secondary prophylaxis in a patient on highly active antiretroviral therapy with a CD4 cell count greater than 200/mm3.

AIDS. 2001 Sep 28;15(14):1912-3. doi: 10.1097/00002030-200109280-00034.

9

Pneumocystis carinii pneumonia following discontinuation of primary prophylaxis despite highly active antiretroviral therapy.

Int J STD AIDS. 2000 Jan;11(1):64-5. doi: 10.1258/0956462001914805.

10

Prognostic value of cross-sectional anthropometric indices on short-term risk of mortality in human immunodeficiency virus-infected adults in Abidjan, Côte d'Ivoire.

Am J Epidemiol. 2001 Jul 1;154(1):75-84. doi: 10.1093/aje/154.1.75.

引用本文的文献

1

A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa.

N Engl J Med. 2014 Jan 2;370(1):41-53. doi: 10.1056/NEJMoa1214901.

2

Preventing bacterial disease in the HIV-infected of sub-Saharan Africa: the role of cotrimoxazole and the pneumococcal vaccines.

Curr HIV/AIDS Rep. 2007 Aug;4(3):141-6. doi: 10.1007/s11904-007-0021-x.